Peripheral Arterial Disease: Features

During the Wednesday afternoon CLI Wound session at AMP, Caroline E. Fife, MD, from Baylor College of Medicine in Houston, Texas, delivered a thought-provoking presentation on elevating the CLI patient’s voice and doing the right thing. She...

On Wednesday morning, Chris Fox, senior vice president of external affairs at the American Diabetes Association (ADA), presented the latest information on the ADA’s Amputation Prevention Alliance (APA). 

At Wednesday’s session on CLI in 2024, Laiq Raja, MD, FACC, FSCAI, from El Paso Cardiology Associates in El Paso, Texas, presented on the effective management of complex critical limb ischemia (CLI) patients with wounds in an outpatient...

On the first day of AMP 2024, Yolanda Bryce, MD, RPVI, from Memorial Sloan Kettering Cancer Center in New York, spoke about the complex goals of critical limb ischemia (CLI) therapy, emphasizing the nuanced balance between achieving...

At the 2024 SIR Meeting in Salt Lake City, Utah, interventional radiologist Mark Lessne, MD presented several sessions, including “Beyond Paclitaxel." VDM spoke with Dr. Lessne about his presentation and the future of PAD management.

At the 2024 SIR Meeting, Waseem Wahood, MD, MS presented results from a study that analyzed 30-day perioperative outcomes from the National Surgical Quality Improvement Project in patients who received intervention for CLTI.

The clinical realities of big trials such as BEST-CLI and BASIL-2 were dissected by Dr. Tatsuya Nakama in a session that explored strategic visions for the future of below-the-knee interventions.

An introduction to a new trial focused on aggressive vessel preparation took center stage on Wednesday as part of a ‘last frontiers’ session tackling severely calcified lesions. Tim Wittig detailed the CRACK-IT trial.